Golgi protein-73 (GP73), a resident Golgi glycoprotein, is upregulated in serum samples from patients with liver diseases, especially those with HCC, and is expected to be a new serum marker for the diagnosis of HCC 13. This evidence concerns the gene ART4 and hepatocellular carcinoma.